Adam Greene is a Partner on the Pharmaceuticals team at Deerfield and joined the Firm in 2010. Prior to Deerfield, he was a pharmaceutical analyst on the sell-side for seventeen years at several firms, including RBC Capital Markets, JPMorgan and First Albany. Throughout his career, Mr. Greene’s sell-side research was focused on generic drug manufacturers as well as large cap and specialty pharmaceuticals. Mr. Greene holds a B.S. in Finance from Lehigh University.
Brian Bizoza, M.D.
Brian Bizoza, M.D., is a Partner on the Pharmaceuticals group at Deerfield and joined the Firm in 2012. He provides extensive research and analysis on individual companies operating in the healthcare industry. Prior to Deerfield, Dr. Bizoza spent seven years as a Portfolio Manager at S Squared Technology, where he was responsible for investments across the healthcare sector. Before S Squared, Dr. Bizoza was an analyst at Amaranth Advisors, focused on pharmaceuticals and biotechnology stocks. Dr. Bizoza started his career in healthcare research as an equity analyst at both Lehman Brothers and Lazard Frères. He holds a B.A. in Natural Sciences/Public Health from Johns Hopkins University and earned his M.D. from the State University of New York at Syracuse, where he graduated as a member of Alpha Omega Alpha. Dr. Bizoza is a Member of the Advisory Board of The Krieger School of Arts & Sciences at Johns Hopkins University.